CX NEWS
CX 2024: Aortic Programme forefronts cutting-edge edited cases “on film” and multiple top-notch debates
Tilo Kölbel (vascular surgeon from Hamburg, Germany, and a member of the Executive Board for the Aortic Programme) makes the case for moving images that will "easily transport" vascular surgeons and interventionalists. He also has his eye [...]
CX 2024: Brand new data on cyanoacrylate glue, bioprosthetic valves and intensive pulmonary embolism treatments
Manj Gohel (Cambridge, UK) and member of the Venous Executive Board parachutes straight into the CX Venous and Lymphatics Controversies Programme to highlight the VenaSeal SPECTRUM programme, SAVVE trial and SYNCHRONOUS trial, which [...]
CX 2024: Get a ringside seat for the big BASIL-3 data reveal
No more freestyling, reset your endovascular CLTI practice with new Level 1 evidence Andrew Bradbury (Birmingham, UK) and the BASIL-3 team of triallists will be presenting, for the very first time, the results [...]
45 Year Legacy of CX Vascular Education Continues
Three newly appointed Charing Cross International Symposium (CX) Co-chairs will ensure Roger Greenhalgh’s inspiring legacy of vascular education continues at CX 2024 with the 46th CX Symposium. Dittmar Böckler (Heidelberg, Germany), Andrew Holden (Auckland, [...]
CX 2024: Chairman’s Address
Filmed in the newly completed CX Studio, CX Chair Professor Roger Greenhalgh (London, UK), outlines the plans for CX 2024. Now in its 46th year, the Charing Cross Symposium continues to champion world-class education, innovation and [...]
CX 2024: The Delegate Perspective
What to Expect In-Person @ CX 2024 I attend CX to network with international colleagues in the field of vascular surgery. The best part of CX was seeing my colleagues again in-person after the [...]